These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37077394)

  • 1. Development and Characterization of Fluorescent Probes for the G Protein-Coupled Receptor 35.
    Wei L; Xiang K; Kang H; Yu Y; Fan H; Zhou H; Hou T; Ge Y; Wang J; Guo Z; Chen Y; Zhao Y; Liang X
    ACS Med Chem Lett; 2023 Apr; 14(4):411-416. PubMed ID: 37077394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Characterization of a Fluorescent Tracer for the Free Fatty Acid Receptor 2 (FFA2/GPR43).
    Hansen AH; Sergeev E; Pandey SK; Hudson BD; Christiansen E; Milligan G; Ulven T
    J Med Chem; 2017 Jul; 60(13):5638-5645. PubMed ID: 28570808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-free phenotypic profiling identified D-luciferin as a GPR35 agonist.
    Hu H; Deng H; Fang Y
    PLoS One; 2012; 7(4):e34934. PubMed ID: 22511974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput identification and characterization of novel, species-selective GPR35 agonists.
    Neetoo-Isseljee Z; MacKenzie AE; Southern C; Jerman J; McIver EG; Harries N; Taylor DL; Milligan G
    J Pharmacol Exp Ther; 2013 Mar; 344(3):568-78. PubMed ID: 23262279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAR Studies of
    Wei L; Hou T; Lu C; Wang J; Zhang X; Fang Y; Zhao Y; Feng J; Li J; Qu L; Piao HL; Liang X
    ACS Med Chem Lett; 2018 May; 9(5):422-427. PubMed ID: 29795753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonists of GPR35 display high species ortholog selectivity and varying modes of action.
    Jenkins L; Harries N; Lappin JE; MacKenzie AE; Neetoo-Isseljee Z; Southern C; McIver EG; Nicklin SA; Taylor DL; Milligan G
    J Pharmacol Exp Ther; 2012 Dec; 343(3):683-95. PubMed ID: 22967846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRET- and fluorescence anisotropy-based assays for real-time monitoring of ligand binding to M
    Grätz L; Laasfeld T; Allikalt A; Gruber CG; Pegoli A; Tahk MJ; Tsernant ML; Keller M; Rinken A
    Biochim Biophys Acta Mol Cell Res; 2021 Mar; 1868(3):118930. PubMed ID: 33347921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.
    Jenkins L; Brea J; Smith NJ; Hudson BD; Reilly G; Bryant NJ; Castro M; Loza MI; Milligan G
    Biochem J; 2010 Dec; 432(3):451-9. PubMed ID: 20919992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 2-(4-methylfuran-2(5H)-ylidene)malononitrile and thieno[3,2-b]thiophene-2-carboxylic acid derivatives as G protein-coupled receptor 35 (GPR35) agonists.
    Deng H; Hu H; He M; Hu J; Niu W; Ferrie AM; Fang Y
    J Med Chem; 2011 Oct; 54(20):7385-96. PubMed ID: 21950657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Label-Free Cell Phenotypic Identification of D-Luciferin as an Agonist for GPR35.
    Hu H; Deng H; Fang Y
    Methods Mol Biol; 2016; 1461():3-17. PubMed ID: 27424891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent Ligand-Based Discovery of Small-Molecule Sulfonamide Agonists for GPR120.
    Ma S; Li Z; Yang Y; Zhang L; Li M; Du L
    Front Chem; 2022; 10():816014. PubMed ID: 35174139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioluminescence resonance energy transfer methods to study G protein-coupled receptor-receptor tyrosine kinase heteroreceptor complexes.
    Borroto-Escuela DO; Flajolet M; Agnati LF; Greengard P; Fuxe K
    Methods Cell Biol; 2013; 117():141-64. PubMed ID: 24143976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35.
    Funke M; Thimm D; Schiedel AC; Müller CE
    J Med Chem; 2013 Jun; 56(12):5182-97. PubMed ID: 23713606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel BRET-based binding assay for interaction studies of relaxin family peptide receptor 3 with its ligands.
    Wang JH; Shao XX; Hu MJ; Wei D; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2017 May; 49(5):895-903. PubMed ID: 28161795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel GPR35 agonist with high and equipotent species potency for oral treatment of IBD.
    Song Z; Lu D; Sun J; Ye Y; Fang J; Wang K; Guo S; Zhang Q; He X; Xie X; Shen J
    Bioorg Med Chem; 2023 Dec; 96():117511. PubMed ID: 37976806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Bromo-8-(4-[(3)H]methoxybenzamido)-4-oxo-4H-chromene-2-carboxylic Acid: a powerful tool for studying orphan G protein-coupled receptor GPR35.
    Thimm D; Funke M; Meyer A; Müller CE
    J Med Chem; 2013 Sep; 56(17):7084-99. PubMed ID: 23888932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in GPR35 pharmacology; 5-HIAA serotonin metabolite becomes a ligand.
    Im DS
    Arch Pharm Res; 2023 Jun; 46(6):550-563. PubMed ID: 37227682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 2H-Chromen-2-one Derivatives as G Protein-Coupled Receptor-35 Agonists.
    Wei L; Wang J; Zhang X; Wang P; Zhao Y; Li J; Hou T; Qu L; Shi L; Liang X; Fang Y
    J Med Chem; 2017 Jan; 60(1):362-372. PubMed ID: 27976894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthologue selectivity and ligand bias: translating the pharmacology of GPR35.
    Milligan G
    Trends Pharmacol Sci; 2011 May; 32(5):317-25. PubMed ID: 21392828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertion of Nanoluc into the Extracellular Loops as a Complementary Method To Establish BRET-Based Binding Assays for GPCRs.
    Grätz L; Müller C; Pegoli A; Schindler L; Bernhardt G; Littmann T
    ACS Pharmacol Transl Sci; 2022 Nov; 5(11):1142-1155. PubMed ID: 36407949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.